AI-facilitated individualized nutritional guidance with ABC-structured prompts improves short-term dietary intake adequacy and patient-reported symptoms after gastrointestinal cancer surgery: a randomized controlled trial.

Support Care CancerOct 29, 2026 (epub)

Hao Chen, Wei Jiang, Meng Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This single-center randomized controlled trial compared AI-facilitated, individualized and quantified dietary guidance plus clinician review with standard discharge advice in 90 patients after laparoscopic gastric or colorectal cancer surgery. At 30 days after discharge, energy intake adequacy (at least 90% of target) was achieved by 66.7% versus 40.0% of patients (OR 3.0, 95% CI 1.3-7.1, P = 0.01); protein adequacy was also higher. The intervention group reported improvements in several symptoms and required less provider time. The combined intervention does not establish an independent benefit from AI.

Key findings

  • At 30 days, energy adequacy was 66.7% vs. 40.0% (OR 3.0, 95% CI 1.3-7.1, P = 0.01).
  • Protein adequacy was 62.2% vs. 35.6% (OR 2.9, 95% CI 1.2-6.8, P = 0.01).
  • GSRS total score was 2.1 vs. 2.5 (P = 0.03), with reported improvements in fatigue, nausea/vomiting, appetite loss, and gastrointestinal symptoms.
  • Provider time per patient was 8.2 vs. 12.5 min (P < 0.001); weight change, serum nutritional markers, and complication rates did not differ significantly.

Why it matters

Post-discharge dietary advice after gastrointestinal cancer surgery may be more useful when tailored and quantified: this trial found better short-term intake adequacy and symptom reports than with generic advice. The findings also suggest a potential workflow benefit. However, the intervention bundled AI with individualization, written targets, and clinician review, so the results inform the package rather than AI's independent contribution.

What to keep in mind

The trial was single-center and assessed short-term outcomes. Because AI was combined with individualized quantified guidance and clinician review, its independent effect cannot be determined; longer-term nutritional or clinical benefit was not established.

Source

Published in Support Care Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.